Atıf Formatları
Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Mert Et Al. , "Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions," Scientific Reports , vol.14, no.1, 2024

Mert, A. Et Al. 2024. Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions. Scientific Reports , vol.14, no.1 .

Mert, A., Derin, O., Akalın, H., Dumlu, R., Gündeş, S., Zengin, R., ... Kocagöz, S.(2024). Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions. Scientific Reports , vol.14, no.1.

Mert, Ali Et Al. "Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions," Scientific Reports , vol.14, no.1, 2024

Mert, Ali Et Al. "Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions." Scientific Reports , vol.14, no.1, 2024

Mert, A. Et Al. (2024) . "Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions." Scientific Reports , vol.14, no.1.

@article{article, author={Ali Mert Et Al. }, title={Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions}, journal={Scientific Reports}, year=2024}